Anuska Llano

Title: Anuska Llano: Innovator in HIV-1 Treatment

Introduction

Anuska Llano is a notable inventor based in Castellar del Valles, Spain. She has made significant contributions to the field of immunology, particularly in the treatment of HIV-1 infection. With a total of four patents to her name, her work focuses on innovative methods for combating this serious health issue.

Latest Patents

Anuska Llano's latest patents include a method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes. This invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom, which are useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also encompasses isolated nucleic acids, vectors, and host cells expressing these immunogens, as well as vaccines that include said immunogens.

Career Highlights

Throughout her career, Anuska has worked with prominent organizations such as Fundació Privada Institut De Recerca De La Sida—Caixa and Laboratorios del Dr. Esteve S.A. Her experience in these institutions has allowed her to develop and refine her innovative approaches to HIV treatment.

Collaborations

Anuska has collaborated with esteemed colleagues in her field, including Christian Brander and Beatriz Mothe Pujadas. These partnerships have contributed to her research and the advancement of her inventions.

Conclusion

Anuska Llano is a pioneering inventor whose work in HIV-1 treatment has the potential to make a significant impact on public health. Her innovative patents and collaborations highlight her dedication to advancing medical science.